ROBITUSSIN ANTITUSSICUM NA SUCHÝ DRÁŽDIVÝ KAŠEL - interactions (all)

The metabolism of Dextromethorphan can be decreased when combined with Zafirlukast.
The serum concentration of Dextromethorphan can be increased when it is combined with Panobinostat.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Dapiprazole.
The metabolism of Dextromethorphan can be increased when combined with Nevirapine.
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Dextromethorphan.
The serum concentration of Dextromethorphan can be decreased when it is combined with Rilpivirine.
The serum concentration of Dextromethorphan can be increased when it is combined with Palbociclib.
The metabolism of Dextromethorphan can be decreased when combined with Tamoxifen.
The metabolism of Dextromethorphan can be decreased when combined with Chloramphenicol.
The metabolism of Dextromethorphan can be decreased when combined with Topiramate.
The metabolism of Dextromethorphan can be decreased when combined with Zucapsaicin.
The serum concentration of Ranolazine can be increased when it is combined with Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Doxorubicin.
The metabolism of Dextromethorphan can be decreased when combined with Clobazam.
The serum concentration of Metoprolol can be increased when it is combined with Dextromethorphan.
Rasagiline may increase the serotonergic activities of Dextromethorphan.
Zimelidine may increase the serotonergic activities of Dextromethorphan.
Octamoxin may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Promazine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Sertindole.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Thioproperazine.
The serum concentration of Dextromethorphan can be decreased when it is combined with Bosentan.
The metabolism of Dextromethorphan can be decreased when combined with Nicardipine.
Trans-2-Phenylcyclopropylamine may increase the serotonergic activities of Dextromethorphan.
The serum concentration of Dextromethorphan can be increased when it is combined with Fusidic Acid.
Phenoxypropazine may increase the serotonergic activities of Dextromethorphan.
Amphetamine may increase the serotonergic activities of Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Perospirone.
The serum concentration of Dextromethorphan can be increased when it is combined with Osimertinib.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Promethazine.
Procarbazine may increase the serotonergic activities of Dextromethorphan.
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Sumatriptan.
The metabolism of Dextromethorphan can be decreased when combined with Atazanavir.
The metabolism of Dextromethorphan can be decreased when combined with Nelfinavir.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Tiapride.
Citalopram may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Ziprasidone.
The serum concentration of Topotecan can be increased when it is combined with Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Thiotepa.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Metoclopramide.
The metabolism of Dextromethorphan can be decreased when combined with Betaxolol.
The serum concentration of Doxorubicin can be increased when it is combined with Dextromethorphan.
The serum concentration of Vincristine can be increased when it is combined with Dextromethorphan.
Tropisetron may increase the serotonergic activities of Dextromethorphan.
The serum concentration of Dextromethorphan can be increased when it is combined with Quinidine.
The serum concentration of Dextromethorphan can be increased when it is combined with Darunavir.
The metabolism of Dextromethorphan can be increased when combined with Rifampicin.
The risk or severity of adverse effects can be increased when Protriptyline is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Pipotiazine.
Dolasetron may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Doxycycline.
Fluvoxamine may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Diphenhydramine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Olanzapine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Linezolid.
The metabolism of Dextromethorphan can be decreased when combined with Telithromycin.
The metabolism of Dextromethorphan can be decreased when combined with Fluconazole.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Paliperidone.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Fluphenazine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Prochlorperazine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Amperozide.
The metabolism of Dextromethorphan can be decreased when combined with Omeprazole.
The risk or severity of adverse effects can be increased when Methadone is combined with Dextromethorphan.
Moclobemide may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be increased when combined with Carbamazepine.
The metabolism of Dextromethorphan can be decreased when combined with Amiodarone.
Pheniprazine may increase the serotonergic activities of Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Ergoloid mesylate.
The metabolism of Dextromethorphan can be decreased when combined with Clopidogrel.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Maprotiline.
The metabolism of Dextromethorphan can be decreased when combined with Crisaborole.
The metabolism of Dextromethorphan can be decreased when combined with Mirabegron.
The metabolism of Dextromethorphan can be decreased when combined with Sulfisoxazole.
The serum concentration of Edoxaban can be increased when it is combined with Dextromethorphan.
The serum concentration of Dextromethorphan can be decreased when it is combined with Siltuximab.
Harmaline may increase the serotonergic activities of Dextromethorphan.
The serum concentration of Dextromethorphan can be decreased when it is combined with Peginterferon alfa-2b.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Almotriptan.
The risk or severity of adverse effects can be increased when Trazodone is combined with Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Manidipine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Bifeprunox.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Risperidone.
Pirlindole may increase the serotonergic activities of Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Brexpiprazole.
Paroxetine may increase the serotonergic activities of Dextromethorphan.
Dapoxetine may increase the serotonergic activities of Dextromethorphan.
The serum concentration of Dextromethorphan can be increased when it is combined with Simeprevir.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Droperidol.
The metabolism of Dextromethorphan can be decreased when combined with Artemether.
Toloxatone may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Valsartan.
The metabolism of Dextromethorphan can be decreased when combined with Pioglitazone.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Pipamperone.
The metabolism of Dextromethorphan can be decreased when combined with Dosulepin.
Pargyline may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Darifenacin.
The metabolism of Dextromethorphan can be decreased when combined with Fluorouracil.
The serum concentration of Dextromethorphan can be increased when it is combined with Abiraterone.
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Loxapine.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Asenapine.
Iproniazid may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Imatinib.
The metabolism of Dextromethorphan can be decreased when combined with Gemfibrozil.
The metabolism of Dextromethorphan can be decreased when combined with Ritonavir.
The serum concentration of Prucalopride can be increased when it is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Nortriptyline.
Hydracarbazine may increase the serotonergic activities of Dextromethorphan.
The serum concentration of Dextromethorphan can be increased when it is combined with Ivacaftor.
The metabolism of Dextromethorphan can be decreased when combined with Isavuconazonium.
Granisetron may increase the serotonergic activities of Dextromethorphan.
Furazolidone may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Itraconazole.
The serum concentration of Conivaptan can be increased when it is combined with Dextromethorphan.
Desvenlafaxine may increase the serotonergic activities of Dextromethorphan.
The metabolism of Dextromethorphan can be decreased when combined with Nicotine.
The metabolism of Dextromethorphan can be decreased when combined with Ropinirole.
The serum concentration of Dextromethorphan can be increased when it is combined with Ceritinib.
The serum concentration of Dextromethorphan can be decreased when it is combined with Deferasirox.
The risk or severity of adverse effects can be increased when Cabergoline is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Imipramine is combined with Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Osanetant.
The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Sarilumab.
The metabolism of Dextromethorphan can be decreased when combined with Topiroxostat.
The metabolism of Dextromethorphan can be decreased when combined with Rolapitant.
Nefazodone may increase the serotonergic activities of Dextromethorphan.
Nialamide may increase the serotonergic activities of Dextromethorphan.
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Perphenazine.